Eagle Pharmaceuticals, Inc. Uncategorized Contracts & Agreements

11 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Offer Letter, by and between the Company and Michael Graves, dated December 21, 2023
Eagle Pharmaceuticals, Inc.
Biotechnology
NJ
2023
Lock-up Agreement, dated March 27, 2022, by and between Eagle Pharmaceuticals, Inc. and Cosmo Pharmaceuticals N.V
Eagle Pharmaceuticals, Inc.
Biotechnology
DE
2022
Form of Director Undertaking
Eagle Pharmaceuticals, Inc.
Biotechnology
2022
Announcement, dated March 28, 2022
Eagle Pharmaceuticals, Inc.
Biotechnology
2022
Co-Promotion Agreement, dated January 7, 2020, between the Registrant and Tyme Technologies Inc
Eagle Pharmaceuticals, Inc.
Biotechnology
DE
2020
Co-Promotion Agreement with Tyme Technologies, Inc., dated January 7, 2020
Eagle Pharmaceuticals, Inc.
Biotechnology
DE
2020
Description of securities registered pursuant to Section 12 of the Securities Exchange Act of 1934
Eagle Pharmaceuticals, Inc.
Biotechnology
2020
[SIGNATURE PAGE FOLLOWS]
Eagle Pharmaceuticals, Inc.
Biotechnology
NY
2017
CO-PROMOTION AGREEMENT
Eagle Pharmaceuticals, Inc.
Biotechnology
NY
2016
* * *
Eagle Pharmaceuticals, Inc.
Biotechnology
2015
David Riggs
Eagle Pharmaceuticals, Inc.
Biotechnology
2013